iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Some NIH research reviews were delayed by the 2025 lapse in federal appropriations, and NIH has since changed HIV/AIDS application due dates and issued new award guidance under a continuing resolution. These are related but distinct issues: the available evidence does not show that every HIV grant was delayed, cut, or terminated, or that HIV-specific patient outcomes have changed. Much of the documented review and award policy is NIH-wide; the HIV-specific evidence describes portfolio trends through FY 2025.
Were HIV research grants delayed, cut, or canceled?
NIH documented a substantial interruption to its peer-review process after the October 1, 2025 lapse in appropriations. In a November 24 reopening notice, the agency said it had canceled more than 370 peer-review meetings, affecting more than 24,000 applications. Those counts are NIH-wide, not counts of HIV applications. NIH also modified discussion thresholds and summary statements to manage the backlog; delayed January 2026 review work overlapped with the May 2026 council cycle, and modified practices continued through that May cycle. NIH’s reopening notice describes those operational effects.
A review delay is not itself evidence that a grant was denied or that an existing award was terminated. The notices establish disruption to review and describe later award operations; they do not identify which HIV-specific applications or awards, if any, were affected. Likewise, a continuation award issued below a prior level is a reduction in that award’s amount, not proof that the award was canceled.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →What happened during the lapse and reopening?
NIH’s November 24, 2025 notice also provided reopening instructions, including late-submission accommodations for affected deadlines, changes to post-submission materials, and adjustments to peer review. NIH said payments through the Payment Management System should be processing as usual and advised recipients with a held drawdown request to check its status. Those are agency-wide instructions, not a statement about the status of a specific HIV award.
#1 Best Overall
Did NIH change HIV/AIDS grant deadlines?
Yes. Effective May 8, 2026, NIH ended special receipt dates for HIV/AIDS-related applications. From that date, applicants use the standard NIH due date for the relevant activity code or the due date specified in the applicable Notice of Funding Opportunity (NOFO). NIH said applications continue to be accepted three times a year, four months apart, and that the alignment does not change funding decisions or an application’s likelihood of being funded. See NIH’s announcement on aligning HIV/AIDS receipt dates.
The change affects when an application is due and reviewed, not its scientific merit or the probability of an award, according to NIH. NIH cited growth from 32,000 HIV/AIDS-related applications in 1988 to 102,000 in 2025 as part of the reason for simplifying receipt dates. In 2025, fewer than 40% of applications submitted under the special HIV/AIDS dates qualified for them; NIH said applications designated incorrectly were delayed to the next review round.
Rank #2
How to find the right due date
- Identify the application’s activity code and check its current standard NIH due date.
- Read the relevant NOFO and use its date if it specifies one.
- Confirm that any HIV/AIDS designation or other application condition is correct before submission; an incorrect designation previously led to deferral to a later review round.
What does the current continuing resolution mean for NIH awards?
As of October 7, 2026, NIH says it is operating under a continuing resolution (CR) through December 11, 2026, at the FY 2026 enacted level. Under this notice, NIH institutes and centers may, at their discretion, issue non-competing continuation awards below the amount shown in the most recent Notice of Award (NoA). NIH says institutions should monitor spending; upward adjustments are to be considered after FY 2027 appropriations are enacted. The policy is in NIH’s September 28, 2026 continuing-resolution notice.
Free tools Windows power users keep installed
One-click scans. No signup required.
A non-competing continuation is a subsequent budget period of an existing award, rather than a new competitive application. Do not assume the amount in an earlier NoA will necessarily be issued unchanged under the current CR. For an individual award’s adjustment, NIH directs recipients to contact the Grants Management Specialist named in that award’s NoA.
Rank #3
This is distinct from NIH’s earlier FY 2026 fiscal policy. In March, NIH said the Consolidated Appropriations Act, 2026, provided $47.5 billion in NIH program-level funding, including $226 million under the 21st Century Cures Act, 1% above FY 2025. NIH said non-competing continuation awards generally would issue at the commitment level in the NoA, with later periods dependent on appropriations, performance, award terms, and federal interests. Those details are NIH-wide; they are not a separate HIV research allocation. See NIH’s FY 2026 fiscal policies.
How should NIH-wide funding figures be read alongside HIV-specific figures?
Funding figures answer different questions depending on whether they describe all NIH programs, NIH AIDS research, enacted appropriations, or a proposed budget. They should not be treated as interchangeable.
Rank #4
- New
- Mint Condition
- Dispatch same day for order received before 12 noon
- Guaranteed packaging
- No quibbles returns
| Figure or category | What it represents | What it does not establish |
|---|---|---|
| $47.5 billion in FY 2026, including $226 million under the 21st Century Cures Act; 1% above FY 2025 | NIH-wide program-level funding reported by NIH in March 2026 under the Consolidated Appropriations Act, 2026. NIH fiscal policy notice | It is not the HIV/AIDS research allocation or the amount awarded to any particular institute, project, or grant. |
| $3.294 billion in FY 2023 and $3.294 billion in FY 2024 | NIH AIDS research funding figures shown by HIV.gov. HIV.gov federal HIV budget | They do not establish FY 2026 HIV funding or the outcome of an individual grant. HIV.gov labels FY 2025 as a President’s budget request, not enacted spending. |
| OAR Professional Judgment Budget | A funding estimate for the resources needed to pursue scientific opportunities, as described by NIH’s Office of AIDS Research. NIH OAR budget information | It is not a prediction of what Congress will appropriate. |
Use the enacted appropriation to describe money Congress approved, a President’s budget request to describe a proposal, and the OAR Professional Judgment Budget to describe a scientific-needs estimate. The categories answer different questions; a request or estimate cannot be reported as enacted spending.
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Does the HIV research portfolio show rising competition?
At its June 2026 meeting, NIH’s Office of AIDS Research Advisory Council (OARAC) heard that overall NIH HIV funding had remained relatively stable from FY 2019 through FY 2025, while the number of funded projects fluctuated. NIH also reported rising application volume and fewer awards, increasing competition even as average award sizes grew. The council discussion also noted that FY 2025 early-career-investigator awards declined from the record level in FY 2024, while long-term workforce investment remained a priority. These portfolio trends do not establish the status of a specific FY 2026 application or award. Details are in the June 2026 OARAC meeting highlights.
Best Value
Are HIV clinical trials or patient care affected?
A delayed review or uncertain award can create operational uncertainty for research, including the continuity of trial infrastructure. The Infectious Diseases Society of America raised concerns about possible effects on infectious-disease research and clinical-trial networks in an April 2026 letter. That is a stakeholder assessment of risks, not confirmation that a particular HIV trial has stopped.
The sources available here do not provide a current list of HIV grants or trial networks with award-level delays or interruptions, nor do they quantify HIV-specific patient outcomes caused by funding delays. Patients and advocates should verify an individual study’s status with its sponsor, trial site, or public registry before concluding that enrollment, study visits, or care have changed. A general concern about continuity is not evidence of a specific patient impact.
Quick Recap
What should researchers, patients, and advocates do next?
Researchers and institutions
- For a planned application, verify the activity code’s current NIH due date and the applicable NOFO rather than relying on the former HIV/AIDS-specific receipt dates.
- For an existing award, read the latest NoA and notices from the responsible NIH institute or center; do not assume the prior budget-period amount will carry forward unchanged under the CR.
- For questions about a specific award adjustment, contact the Grants Management Specialist named in the NoA. NIH’s continuing-resolution notice also advises institutions to monitor spending.
Patients and advocates
- Ask the trial sponsor or site whether a named study is recruiting and whether visits or procedures have changed.
- When making public claims, distinguish a reported risk to research continuity from a verified trial interruption or a measured change in patient care.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
Do these 3 things before closing this tab:
1Repair Windows errors before they cause bigger problems2Fix the driver behind crashes, sound loss and screen glitches3Clear out junk files and repair common Windows errors
